Moolec Science (MLECW) Accumulated Expenses (2022 - 2025)
Moolec Science (MLECW) posted Accumulated Expenses of $129468.0 for Q4 2025, down 46.86% sequentially from $243634.0 in Q2 2025, and up 87.38% YoY from $69095.0 in Q4 2024.
Moolec Science (MLECW) Accumulated Expenses (2022 - 2025) Analysis & Trends
Moolec Science has reported Accumulated Expenses for 4 years, with the latest figure at $129468.0 in Q4 2025.
- Quarterly Accumulated Expenses rose 87.38% year-over-year to $129468.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $129468.0 (up 87.38% YoY) and the FY2025 annual result came in at $243634.0, down 96.75% from the prior year.
- Accumulated Expenses retreated to $129468.0 in Q4 2025 per MLECW's latest filing, from $243634.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $10.0 million in Q2 2023 and troughed at $69095.0 in Q4 2024.
- A 4-year average of $3.7 million and a median of $2.2 million in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2025: Accumulated Expenses soared 1948.62% in 2023, then slumped 96.75% in 2025.
- Over 4 years, Accumulated Expenses stood at $7.5 million in 2022, then jumped by 32.66% to $10.0 million in 2023, then slumped by 99.31% to $69095.0 in 2024, then surged by 87.38% to $129468.0 in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $129468.0, $243634.0, and $69095.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 129,468.00 |
| Jun 30, 2025 | 243,634.00 |
| Dec 31, 2024 | 69,095.00 |
| Jun 30, 2024 | 7.51 Mn |
| Jun 30, 2023 | 9.95 Mn |
| Mar 31, 2023 | 3.99 Mn |
| Dec 31, 2022 | 7.50 Mn |
| Jun 30, 2022 | 485,735.00 |